Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Petrelintide once-weekly dose-finding trial in adults with obesity or overweight with comorbidities
2024-512549-18-00Phase 2Completed
- Sponsor
- Zealand Pharma
- Start
- Dec 2024
- Modality
- Hormonal Peptides → Native Peptides → Peptides
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial in obesity and Overweight comparing Petrelintide once weekly with Placebo once weekly (2 arms). Primary endpoint: Change in body weight (%) from baseline to week 28. Started Dec 2024; status: completed.
02
Drugs
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on 2024-512549-18-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512549-18-00.